Evidence map›Paper›PMID 30197947›Full record

ReviewJournal of current ophthalmology2018

The prevalence of amblyopia in Iran: A systematic review.

Maryam Chegeni, Narges Khanjani, Pardis Rahmatpour, Mahin Ahmadi Pishkuhi, Nafiseh Abdolalian

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of current ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Binocular Vision Anomalies: An Update on Prevalence, Impact, Technological and Treatment Developments and Current Challenges.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Maryam ChegeniDepartment of Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran.
Narges KhanjaniNeurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Pardis RahmatpourSocial Determinants of Health Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Mahin Ahmadi PishkuhiNoor Research Center For Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran.
Nafiseh AbdolalianIsfahan University of Medical Sciences, Isfahan, Iran.
Kerman University of Medical Sciences · IRGuilan University of Medical Sciences · IRIsfahan University of Medical Sciences · IRNoor Eye Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to determine the prevalence of amblyopia in the population of Iran.

methodsThis article is a systematic review. A comprehensive search was conducted in PubMed, Scopus, Science Direct, Ovid, Web of Science, SID, Magiran, with appropriate terms. Information related to the sample size and the prevalence of amblyopia was extracted and summarized in tables. Analysis was performed using STATA software.

resultsFrom 551 articles that were originally extracted from the databases, 31 articles met the criteria for entering the review. These studies were conducted in different regions of Iran. The prevalence of amblyopia in different regions varied between 0.19 and 3.69%. Study results were heterogeneous (I

conclusionsThe prevalence of amblyopia in Iran is very different. In addition to conducting national screenings, it is necessary to report the incidence of amblyopia and its related factors in different parts of the country.

Indexed as

AmblyopiaIranPrevalenceSystematic review

Identifiers

PMID30197947
PMCPMC6127360
OpenAlexW2794679783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.